Status:
COMPLETED
HD vs SD Quadrivalent Influenza Vaccine in Adults Aged 65 to 79 Years in Galicia
Lead Sponsor:
Federico Martinón Torres
Conditions:
Influenza
Eligibility:
All Genders
65-79 years
Phase:
PHASE4
Brief Summary
This pragmatic randomized trial is designed to evaluate the relative vaccine effectiveness of QIV-HD vs. QIV-SD in reducing the risk of hospitalization for influenza or pneumonia in adults 65-79 years...
Detailed Description
The study is a pragmatic, registry-based, open-label, active-controlled, individually randomized trial using the infrastructure of the Regional Vaccination Program of Galicia for patient recruitment, ...
Eligibility Criteria
Inclusion
- 1\. Age 65-79 years residing in the community (only individuals who are not eligible to receive QIV-HD as part of the standard of care)
- 2\. Informed consent form has been signed and dated
Exclusion
- There are no specific exclusion criteria for this study
Key Trial Info
Start Date :
October 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2025
Estimated Enrollment :
134476 Patients enrolled
Trial Details
Trial ID
NCT06141655
Start Date
October 26 2023
End Date
May 31 2025
Last Update
August 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Public Health Directorate of Galician Health Service
Santiago de Compostela, A Coruña, Spain